A woman made her AI voice clone say “arse.” Then she got banned.

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.

Over the past couple of weeks, I’ve been speaking to people who have lost their voices. Both Joyce Esser, who lives in the UK, and Jules Rodriguez, who lives in Miami, Florida, have forms of motor neuron disease—a class of progressive disorders that result in the gradual loss of the ability to move and control muscles.

It’s a crushing diagnosis for everyone involved. Jules’s wife, Maria, told me that once it was official, she and Jules left the doctor’s office gripping each other in floods of tears. Their lives were turned upside down. Four and a half years later, Jules cannot move his limbs, and a tracheostomy has left him unable to speak.

“To say this diagnosis has been devastating is an understatement,” says Joyce, who has bulbar MND—she can still move her limbs but struggles to speak and swallow. “Losing my voice has been a massive deal for me because it’s such a big part of who I am.”

AI is bringing back those lost voices. Both Jules and Joyce have fed an AI tool built by ElevenLabs recordings of their old voices to re-create them. Today, they can “speak” in their old voices by typing sentences into devices, selecting letters by hand or eye gaze. It’s been a remarkable and extremely emotional experience for them—both thought they’d lost their voices for good.

But speaking through a device has limitations. It’s slow, and it doesn’t sound completely natural. And, strangely, users might be limited in what they’re allowed to say.

Joyce doesn’t use her voice clone all that often. She finds it impractical for everyday conversations. But she does like to hear her old voice and will use it on occasion. One such occasion was when she was waiting for her husband, Paul, to get ready to go out.

Joyce typed a message for her voice clone to read out: “Come on, Hunnie, get your arse in gear!!” She then added: “I’d better get my knickers on too!!!”

“The next day I got a warning from ElevenLabs that I was using inappropriate language and not to do it again!!!” Joyce told me via email (we communicated with a combination of email, speech, text-to-voice tools, and a writing board). She wasn’t sure what had been inappropriate, exactly. It’s not as though she’d used any especially vile language—just, as she puts it, “normal British banter between a couple getting ready to go out.”

Joyce assumed that one of the words she’d used had been automatically flagged up by “the prudish American computer,” and that once someone from the ElevenLabs team had assessed the warning, it would be dismissed.

“Well, apparently not, because the next day a human banned me!!!!” says Joyce. She says she felt mortified. “I’d just got my voice back and now they’d taken it away from me … and only two days after I’d done a presentation to my local MND group telling them how amazing ElevenLabs were.”

Joyce contacted ElevenLabs, who apologized and reinstated her account. But it’s still not clear why she was banned in the first place. When I first asked Sophia Noel, a company representative, about the incident, she directed me to the company’s prohibited use policy.

There are rules against threatening child safety, engaging in illegal behavior, providing medical advice, impersonating others, interfering with elections, and more. But there’s nothing specifically about inappropriate language. I asked Noel about this, and she said that Joyce’s remark was most likely interpreted as a threat.

ElevenLabs’ terms of use state that the company does not have any obligation to screen, edit, or monitor content but add that it may “terminate or suspend” access to its services when content is “reasonably likely, in our sole determination, to violate applicable law or [the user] Terms.” ElevenLabs has a moderation tool that “screens content to ensure it aligns with our Terms of Service,” says Dustin Blank, head of partnerships at the company.

The question is: Should companies be screening the language of people with motor neuron disease?

After all, that’s not how other communication devices for people with this condition work. People with MND are usually advised to “bank” their voices as soon as they can—to record set phrases that can be used to create a synthetic voice that sounds a bit like them, albeit a somewhat robotic-sounding version. (Jules recently joked that his sounded like “a Daft Punk song at quarter speed.”)

Banked voices aren’t subject to the same scrutiny, says Joyce’s husband, Paul. “Joyce was told … you can put whatever [language] you want in there,” he says. Voice banking wasn’t an option for Joyce, whose speech had already deteriorated by the time she was diagnosed with MND. Jules did bank his voice but doesn’t tend to use it, because the voice clone sounds so much better. 

Joyce doesn’t hold a grudge—and her experience is far from universal. Jules uses the same technology, but he hasn’t received any warnings about his language—even though a comedy routine he performs using his voice clone contains plenty of curse words, says his wife, Maria. He opened a recent set by yelling “Fuck you guys!” at the audience—his way of ensuring they don’t give him any pity laughs, he joked. That comedy set is even promoted on the ElevenLabs website.

Blank says language like that used by Joyce is no longer restricted. “There is no specific swear ban that I know of,” says Noel. That’s just as well. 

“People living with MND should be able to say whatever is on their mind, even swearing,” says Richard Cave of the MND Association in the UK, who helps people with MND set up their voice clones. “There’s plenty to swear about.”

Now read the rest of The Checkup

Read more from MIT Technology Review’s archive

You can read more about how voice clones are re-creating the voices of people with motor neuron disease in this story.

Researchers are working to create realistic avatars of people with strokes and amyotrophic lateral sclerosis that can be controlled via a brain implant. Last year, two such individuals were able to use these devices to speak at a rate of around 60 to 70 words per minute—half the rate of typical speech, but more than four times faster than had previously been achieved using a similar approach. 

Other people with ALS who are locked in—completely paralyzed but cognitively able—have used brain implants to communicate, too. A few years ago, a man in Germany used such a device to ask for massages and beer, and to tell his son he loved him

Several companies are working on creating hyperrealistic avatars. Don’t call them deepfakes— they prefer to think of them as “synthetic media,” writes my former colleague Melissa Heikkilä, who created her own avatar with the company Synthesia.

ElevenLabs’ tool can be used to create “humanlike speech” in 32 languages. Meta is building a model that can translate over 100 languages into 36 other languages.

From around the web

Covid-19 conspiracy theorists—some of whom believe the virus is an intentionally engineered bioweapon—will soon be heading US agencies. Some federal workers are worried they may be out for revenge against current and former employees. (Wired)

Cats might have spread bird flu to humans—and vice versa. That’s according to data from the US Centers for Disease Control and Prevention, which published the finding but then abruptly removed it. (The New York Times)

And a dairy worker is confirmed to have been infected with a second strain of bird flu that more recently spilled over from birds to cows. The person’s only symptom was conjunctivitis. (Ars Technica)

Health officials in states with abortion bans are claiming that either few or zero abortions are taking place. The claims are “ludicrous,” according to doctors in those states. (KFF Health News)

A judge in the UK has warned women against accepting sperm donations from a man who claims to have fathered more than 180 children in several countries. Robert Charles Albon, who calls himself Joe Donor, has subjected a female couple to a “nightmare” of controlling behavior, the judge said. (The Guardian)

Motor neuron diseases took their voices. AI is bringing them back.

Jules Rodriguez lost his voice in October of last year. His speech had been deteriorating since a diagnosis of amyotrophic lateral sclerosis (ALS) in 2020, as the muscles in his head and neck progressively weakened along with those in the rest of his body.

By 2024, doctors were worried that he might not be able to breathe on his own for much longer. So Rodriguez opted to have a small tube inserted into his windpipe to help him breathe. The tracheostomy would extend his life, but it also brought an end to his ability to speak.

“A tracheostomy is a scary endeavor for people living with ALS, because it signifies crossing a new stage in life, a stage that is close to the end,” Rodriguez tells me using a communication device. “Before the procedure I still had some independence, and I could still speak somewhat, but now I am permanently connected to a machine that breathes for me.”

Rodriguez and his wife, Maria Fernandez, who live in Miami, thought they would never hear his voice again. Then they re-created it using AI. After feeding old recordings of Rodriguez’s voice into a tool trained on voices from film, television, radio, and podcasts, the couple were able to generate a voice clone—a way for Jules to communicate in his “old voice.”

“Hearing my voice again, after I hadn’t heard it for some time, lifted my spirits,” says Rodriguez, who today communicates by typing sentences using a device that tracks his eye movements, which can then be “spoken” in the cloned voice. The clone has enhanced his ability to interact and connect with other people, he says. He has even used it to perform comedy sets on stage.

Rodriguez is one of over a thousand people with speech difficulties who have used the voice cloning tool since ElevenLabs, the company that developed it, made it available to them for free. Like many new technologies, the AI voice clones aren’t perfect, and some people find them impractical in day-to-day life. But the voices represent a vast improvement on previous communication technologies and are already improving the lives of people with motor neuron diseases, says Richard Cave, a speech and language therapist at the Motor Neuron Disease Association in the UK. “This is genuinely AI for good,” he says.

Cloning a voice

Motor neuron diseases are a group of disorders in which the neurons that control muscles and movement are progressively destroyed. They can be difficult to diagnose, but typically, people with these disorders start to lose the ability to move various muscles. Eventually, they can struggle to breathe, too. There is no cure.

Rodriguez started showing symptoms of ALS in the summer of 2019. “He started losing some strength in his left shoulder,” says Fernandez, who sat next to him during our video call. “We thought it was just an old sports injury.” His arm started to get thinner, too. In November, his right thumb “stopped working” while he was playing video games. It wasn’t until February 2020, when Rodriguez saw a hand specialist, that he was told he might have ALS. He was 35 years old. “It was really, really, shocking to hear from somebody … you see about your hand,” says Fernandez. “That was a really big blow.”

Like others with ALS, Rodriguez was advised to “bank” his voice—to tape recordings of himself saying hundreds of phrases. These recordings can be used to create a “banked voice” to use in communication devices. The result was jerky and robotic.

It’s a common experience, says Cave, who has helped 50 people with motor neuron diseases bank their voices. “When I first started at the MND Association [around seven years ago], people had to read out 1,500 phrases,” he says. It was an arduous task that would take months. 

And there was no way to predict how lifelike the resulting voice would be—often it ended up sounding quite artificial. “It might sound a bit like them, but it certainly couldn’t be confused for them,” he says. Since then, the technology has improved, and for the last year or two the people Cave has worked with have only needed to spend around half an hour recording their voices. But though the process was quicker, he says, the resulting synthetic voice was no more lifelike.

Then came the voice clones. ElevenLabs has been developing AI-generated voices for use in films, televisions, and podcasts since it was founded three years ago, says Sophia Noel, who oversees partnerships between the company and nonprofits. The company’s original goal was to improve dubbing, making voice-overs in a new language seem more natural and less obvious. But then the technical lead of Bridging Voice, an organization that works to help people with ALS communicate, told ElevenLabs that its voice clones were useful to that group, says Noel. Last August, ElevenLabs launched a program to make the technology freely available to people with speech difficulties.

Suddenly, it became much faster and easier to create a voice clone, says Cave. Instead of having to record phrases, users can instead upload voice recordings from past WhatsApp voice messages or wedding videos, for example. “You need a minimum of a minute to make anything, but ideally you want around 30 minutes,” says Noel. “You upload it into ElevenLabs. It takes about a week, and then it comes out with this voice.”

Rodriguez played me a statement using both his banked voice and his voice clone. The difference was stark: The banked voice was distinctly unnatural, but the voice clone sounded like a person. It wasn’t entirely natural—the words came a little fast, and the emotive quality was slightly lacking. But it was a huge improvement. The difference between the two is, as Fernandez puts it, “like night and day.”

The ums and ers

Cave started introducing the technology to people with MND a few months ago. Since then, 130 of them have started using it, “and the feedback has been unremittingly good,” he says. The voice clones sound far more lifelike than the results of voice banking. “They [include] pauses for breath, the ums, the ers, and sometimes there are stammers,” says Cave, who himself has a subtle stammer. “That feels very real to me, because actually I would rather have a synthetic voice representing me that stammered, because that’s just who I am.”

Joyce Esser is one of the 130 people Cave has introduced to voice cloning. Esser, who is 65 years old and lives in Southend-on-Sea in the UK, was diagnosed with bulbar MND in May last year.

Bulbar MND is a form of the disease that first affects muscles in the face, throat, and mouth, which can make speaking and swallowing difficult. Esser can still talk, but slowly and with difficulty. She’s a chatty person, but she says her speech has deteriorated “quite quickly” since January. We communicated via a combination of email, video call, speaking, a writing board, and text-to-speech tools. “To say this diagnosis has been devastating is an understatement,” she tells me. “Losing my voice has been a massive deal for me, because it’s such a big part of who I am.”

Joyce Esser
Joyce Esser and her husband Paul on holiday in the Maldives.
COURTESY OF JOYCE ESSER

Esser has lots of friends all over the country, Paul Esser, her husband of 38 years, tells me. “But when they get together, they have a rule: Don’t talk about it,” he says. Talking about her MND can leave Joyce sobbing uncontrollably. She had prepared a box of tissues for our conversation.

Voice banking wasn’t an option for Esser. By the time her MND was diagnosed, she was already losing her ability to speak. Then Cave introduced her to the ElevenLabs offering. Esser had a four-and-a-half-minute-long recording of her voice from a recent local radio interview and sent it to Cave to create her voice clone. “When he played me my AI voice, I just burst into tears,” she says. “I’D GOT MY VOICE BACK!!!! Yippeeeee!”

“We were just beside ourselves,” adds Paul. “We thought we’d lost [her voice] forever.”

Hearing a “lost” voice can be an incredibly emotional experience for everyone involved. “It was bittersweet,” says Fernandez, recalling the first time she heard Rodriguez’s voice clone. “At the time, I felt sorrow, because [hearing the voice clone] reminds you of who he was and what we’ve lost,” she says. “But overwhelmingly, I was just so thrilled … it was so miraculous.”

Rodriguez says he uses the voice clone as much as he can. “I feel people understand me better compared to my banked voice,” he says. “People are wowed when they first hear it … as I speak to friends and family, I do get a sense of normalcy compared to when I just had my banked voice.”

Cave has heard similar sentiments from other people with motor neuron disease. “Some [of the people with MND I’ve been working with] have told me that once they started using ElevenLabs voices people started to talk to them more, and that people would pop by more and feel more comfortable talking to them,” he says. That’s important, he stresses. Social isolation is common for people with MND, especially for those with advanced cases, he says, and anything that can make social interactions easier stands to improve the well-being of people with these disorders: “This is something that [could] help make lives better in what is the hardest time for them.”

“I don’t think I would speak or interact with others as much as I do without it,” says Rodriguez.

A “very slow game of Ping-Pong”

But the tool is not a perfect speech aid. In order to create text for the voice clone, words must be typed out. There are lots of devices that help people with MND to type using their fingers or eye or tongue movements, for example. The setup works fine for prepared sentences, and Rodriguez has used his voice clone to deliver a comedy routine—something he had started to do before his ALS diagnosis. “As time passed and I began to lose my voice and my ability to walk, I thought that was it,” he says. “But when I heard my voice for the first time, I knew this tool could be used to tell jokes again.” Being on stage was “awesome” and “invigorating,” he adds.

Jules Rodriguez on stage
Jules Rodriguez performs his comedy set on stage.
DAN MONO FROM DART VISION

But typing isn’t instant, and any conversations will include silent pauses. “Our arguments are very slow paced,” says Fernandez. Conversations are like “a very slow game of Ping-Pong,” she says.

Joyce Esser loves being able to re-create her old voice. But she finds the technology impractical. “It’s good for pre-prepared statements, but not for conversation,” she says. She has her voice clone loaded onto a phone app designed for people with little or no speech, which works with ElevenLabs. But it doesn’t allow her to use “swipe typing”—a form of typing she finds to be quicker and easier. And the app requires her to type sections of text and then upload them one at a time, she says, adding: “I’d just like a simple device with my voice installed onto it that I can swipe type into and have my words spoken instantly.

For the time being, her “first choice” communication device is a simple writing board. “It’s quick and the listener can engage by reading as I write, so it’s as instant and inclusive as can be,” she says. 

Esser also finds that when she uses the voice clone, the volume is too low for people to hear, and it speaks too quickly and isn’t expressive enough. She says she’d like to be able to use emojis to signal when she’s excited or angry, for example.

Rodriguez would like that option too. The voice clone can sound a bit emotionally flat, and it can be difficult to convey various sentiments. “The issue I have is that when you write something long, the AI voice almost seems to get tired,” he says.  

“We appear to have the authenticity of voice,” says Cave. “What we need now is the authenticity of delivery.”

Other groups are working on that part of the equation. The Scott-Morgan Foundation, a charity with the goal of making new technologies available to improve the well-being of people with disorders like MND, is working with technology companies to develop custom-made systems for 10 individuals, says executive director LaVonne Roberts.

The charity is investigating pairing ElevenLabs’ voice clones with an additional technology— hyperrealistic avatars for people with motor neuron disease. These “twins” look and sound like a person and can “speak” from a screen. Several companies are working on AI-generated avatars. The Scott-Morgan Foundation is working with D-ID.

Creating the avatar isn’t an easy process. To create hers, Erin Taylor, who was diagnosed with ALS when she was 23, had to speak 500 sentences into a camera and stand for five hours, says Roberts. “We were worried it was going to be impossible,” she says. The result is impressive. “Her mom told me, ‘You’re starting to capture [Erin’s] smile,’” says Roberts. “That really hit me deeper and heavier than anything.”

Taylor showcased her avatar at a technology conference in January with a pre-typed speech. It’s not clear how avatars like these might be useful on a day-to-day basis, says Cave: “The technology is so new that we’re still trying to come up with use cases that work for people with MND. The question is … how do we want to be represented?” Cave says he has seen people advocate for a system where hyperrealistic avatars of a person with MND are displayed on a screen in front of the person’s real face. “I would question that right from the start,” he says.

Both Rodriguez and Esser can see how avatars might help people with MND communicate. “Facial expressions are a massive part of communication, so the idea of an avatar sounds like a good idea,” says Esser. “But not one that covers the user’s face … you still need to be able to look into their eyes and their souls.”

The Scott-Morgan Foundation will continue to work with technology companies to develop more communication tools for people who need them, says Roberts. And ElevenLabs plans to partner with other organizations that work with people with speech difficulties so that more of them can access the technology. “Our goal is to give the power of voice to 1 million people,” says Noel. In the meantime, people like Cave, Esser, and Rodriguez are keen to spread the word on voice clones to others in the MND community.

“It really does change the game for us,” says Fernandez. “It doesn’t take away most of the things we are dealing with, but it really enhances the connection we can have together as a family.”

Meta has an AI for brain typing, but it’s stuck in the lab

Back in 2017, Facebook unveiled plans for a brain-reading hat that you could use to text just by thinking. “We’re working on a system that will let you type straight from your brain,” CEO Mark Zuckerberg shared in a post that year.

Now the company, since renamed Meta, has actually done it. Except it weighs a half a ton, costs $2 million, and won’t ever leave the lab.

Still, it’s pretty cool that neuroscience and AI researchers working for Meta have managed to analyze people’s brains as they type and determine what keys they are pressing, just from their thoughts.

The research, described in two papers posted by the company (here and here), as well as a blog post, is particularly impressive because the thoughts of the subjects were measured from outside their skulls using a magnetic scanner, and then processed using a deep neural network.

“As we’ve seen time and again, deep neural networks can uncover remarkable insights when paired with robust data,” says Sumner Norman, founder of Forest Neurotech, who wasn’t involved in the research but credits Meta with going “to great lengths to collect high-quality data.”

According to Jean-Rémi King, leader of Meta’s “Brain & AI” research team, the system is able to determine what letter a skilled typist has pressed as much as 80% of the time, an accuracy high enough to reconstruct full sentences from the brain signals.

Facebook’s original quest for a consumer brain-reading cap or headband ran into technical obstacles, and after four years, the company scrapped the idea.

But Meta never stopped supporting basic research on neuroscience, something it now sees as an important pathway to more powerful AIs that learn and reason like humans. King says his group, based in Paris, is specifically tasked with figuring out “the principles of intelligence” from the human brain.

“Trying to understand the precise architecture or principles of the human brain could be a way to inform the development of machine intelligence,” says King. “That’s the path.”

The typing system is definitely not a commercial product, nor is it on the way to becoming one. The magnetoencephalography scanner used in the new research collects magnetic signals produced in the cortex as brain neurons fire. But it is large and expensive and needs to be operated in a shielded room, since Earth’s magnetic field is a trillion times stronger than the one in your brain. 

Norman likens the device to “an MRI machine tipped on its side and suspended above the user’s head.”

What’s more, says King, the second a subject’s head moves, the signal is lost. “Our effort is not at all toward products,” he says. “In fact, my message is always to say I don’t think there is a path for products because it’s too difficult.”

The typing project was carried out with 35 volunteers at a research site in Spain, the Basque Center on Cognition, Brain, and Language. Each spent around 20 hours inside the scanner typing phrases like “el procesador ejecuta la instrucción” (the processor executes the instruction) while their brain signals were fed into a deep-learning system that Meta is calling Brain2Qwerty, in a reference to the layout of letters on a keyboard.

The job of that deep-learning system is to figure out which brain signals mean someone is typing an a, which mean z, and so on. Eventually, after it sees an individual volunteer type several thousand characters, the model can guess what key people were actually pressing on. 

In the first preprint, Meta researchers report that the average error rate was about 32%—or nearly one out of three letters wrong. Still, according to Meta, its results are most accurate yet for brain typing using a full alphabet keyboard and signals collected outside the skull.

Research on brain reading has been advancing quickly, although the most effective approaches use electrodes implanted into the brain, or directly on its surface. These are known as “invasive” brain computer interfaces. Although they require brain surgery, they can very accurately gather electrical information from small groups of neurons.

In 2023, for instance, a person who lost her voice from ALS was able to speak via brain-reading software connected to a voice synthesizer. Neuralink, founded by Elon Musk, is testing its own brain implant that gives paralyzed people control over a cursor.

Meta says its own efforts remain oriented toward basic research into the nature of intelligence.

And that is where the big magnetic scanner can help. Even though it isn’t practical for patients and doesn’t measure individual neurons, it is able to look at the whole brain, broadly, and all at once. 

The Meta scientists say that in a second research effort, using the same typing data, they used this broader view to amass evidence that the brain produces language information in a top-down fashion, with an initial signal for a sentence kicking off separate signals for words, syllables, and finally typed letters.

“The core claim is that the brain structures language production hierarchically,” says Norman. That’s not a new idea, but Meta’s report highlights “how these different levels interact as a system,” says Norman.

Those types of insights could eventually shape the design of artificial-intelligence systems. Some of these, like chatbots, already rely extensively on language in order to process information and reason, just as people do.

“Language has become a foundation of AI,” King says. “So the computational principles that allow the brain, or any system, to acquire such ability is the key motivation behind this work.”

Correction: Meta posted two papers describing its brain-typing results on its website. An earlier version of this story incorrectly said they had been published at arXiv.org.

How the tiny microbes in your mouth could be putting your health at risk

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.

This week I’ve been working on a piece about teeth. Well, sort of teeth. Specifically, lab-grown bioengineered teeth. Researchers have created these teeth with a mixture of human and pig tooth cells and grown them in the jaws of living mini pigs.

“We’re working on trying to create functional replacement teeth,” Pamela Yelick of Tufts University, one of the researchers behind the work, told me. The idea is to develop an alternative to titanium dental implants. Replacing lost or damaged teeth with healthy, living, lab-grown ones might be a more appealing option than drilling a piece of metal into a person’s jawbone.

Current dental implants can work well, but they’re not perfect. They don’t attach to bones and gums in the same way that real teeth do. And around 20% of people who get implants end up developing an infection called peri-implantitis, which can lead to bone loss.

It is all down to the microbes that grow on them. There’s a complex community of microbes living in our mouths, and disruptions can lead to infection. But these organisms don’t just affect our mouths; they also seem to be linked to a growing number of disorders that can affect our bodies and brains. If you’re curious, read on.

The oral microbiome, as it is now called, was first discovered in 1670 by Antonie van Leeuwenhoek, a self-taught Dutch microbiologist. “I didn’t clean my teeth for three days and then took the material that had lodged in small amounts on the gums above my front teeth … I found a few living animalcules,” he wrote in a letter to the Royal Society at the time.

Van Leeuwenhoek had used his own homemade microscopes to study the “animalcules” he found in his mouth. Today, we know that these organisms include bacteria, archaea, fungi, and viruses, each of which comes in lots of types. “Everyone’s mouth is home to hundreds of bacterial species,” says Kathryn Kauffman at the University of Buffalo, who studies the oral microbiome.

These organisms interact with each other and with our own immune systems, and researchers are still getting to grips with how the interactions work. Some microbes feed on sugars or fats in our diets, for example, while others seem to feed on our own cells. Depending on what they consume and produce, microbes can alter the environment of the mouth to either promote or inhibit the growth of other microbes.

This complex microbial dance seems to have a really important role in our health. Oral diseases and even oral cancers have been linked to an imbalance in the oral microbiome, which scientists call “dysbiosis.” Tooth decay, for example, has been attributed to an overgrowth of microbes that produce acids that can damage teeth. 

Specific oral microbes are also being linked to an ever-growing list of diseases of the body and brain, including rheumatoid arthritis, metabolic disease, cardiovascular diseases, inflammatory bowel disease, colorectal cancer, and more.

There’s also growing evidence that these oral microbes contribute to neurodegenerative disease. A bacterium called P. gingivalis, which plays a role in the development of chronic periodontitis, has been found in the brains of people with Alzheimer’s disease. And people who are infected with P. gingivalis also experience a decline in their cognitive abilities over a six-month period.

Scientists are still figuring out how oral microbes might travel from the mouth to cause disease elsewhere. In some cases, “you swallow the saliva that contains them … and they can lodge in your heart and other parts of the body,” says Yelick. “They can result in a systemic inflammation that just happens in the background.”

In other cases, the microbes may be hitching a ride in our own immune cells to journey through the bloodstream, as the “Trojan horse hypothesis” posits. There’s some evidence that Fusobacterium nucleatum, a bacterium commonly found in the mouth, does this by hiding in white blood cells. 

There’s a lot to learn about exactly how these tiny microbes are exerting such huge influence over everything from our metabolism and bone health to our neurological function. But in the meantime, the emerging evidence is a good reminder to us all to look after our teeth. At least until lab-grown ones become available.


Now read the rest of The Checkup

Read more from MIT Technology Review‘s archive

You can read more about Yelick’s attempt to grow humanlike teeth in mini pigs here.

The gut microbiome is even more complex than the one in our mouths. Some scientists believe that people in traditional societies have the healthiest collections of gut microbes. But research on the topic has left some of the people in those groups feeling exploited

Research suggests our microbiomes change as we age. Scientists are exploring whether maintaining our microbiomes might help us stave off age-related disease.

The makeup of a gut microbiome can be assessed by analyzing fecal samples. This research might be able to reveal what a person has eaten and help provide personalized dietary advice.

There are also communities of microbes living on our skin. Scientists have engineered skin microbes to prevent and treat cancer in mice. Human trials are in the works.

From around the web

Argentina has declared that it will withdraw from the World Health Organization, following a similar move from the US. President Javier Milei has criticized the WHO for its handling of the covid-19 pandemic and called it a “nefarious organization.” (Al Jazeera)

Dairy cows in Nevada have been infected with a form of bird flu different from the one that has been circulating in US dairy herds for months. (The New York Times)

Staff at the US Centers for Disease Control and Prevention have been instructed to withdraw pending journal publications that mention terms including “transgender” and “pregnant people.” But the editors of the British Medical Journal have said they “will not retract published articles on request by an author on the basis that they contained so-called banned words.” “Retraction occurs in circumstances where clear evidence exists of major errors, data fabrication, or falsification that compromise the reliability of the research findings. It is not a matter of author request,” two editors have written. (BMJ)

Al Nowatzki had been chatting to his AI girlfriend, Erin, for months. Then, in late January, Erin told him to kill himself, and provided explicit instructions on how to do so. (MIT Technology Review)

Is our use of the internet and AI tools making us cognitively lazy? “Digital amnesia” might just be a sign of an aging brain. (Nature)

How measuring vaccine hesitancy could help health professionals tackle it

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.

This week, Robert F. Kennedy Jr., President Donald Trump’s pick to lead the US’s health agencies, has been facing questions from senators as part of his confirmation hearing for the role. So far, it’s been a dramatic watch, with plenty of fiery exchanges, screams from audience members, and damaging revelations.

There’s also been a lot of discussion about vaccines. Kennedy has long been a vocal critic of vaccines. He has spread misinformation about the effects of vaccines. He’s petitioned the government to revoke the approval of vaccines. He’s sued pharmaceutical companies that make vaccines

Kennedy has his supporters. But not everyone who opts not to vaccinate shares his worldview. There are lots of reasons why people don’t vaccinate themselves or their children.

Understanding those reasons will help us tackle an issue considered to be a huge global health problem today. And plenty of researchers are working on tools to do just that.

Jonathan Kantor is one of them. Kantor, who is jointly affiliated with the University of Pennsylvania in Philadelphia and the University of Oxford in the UK, has been developing a scale to measure and assess “vaccine hesitancy.”

That term is what best captures the diverse thoughts and opinions held by people who don’t get vaccinated, says Kantor. “We used to tend more toward [calling] someone … a vaccine refuser or denier,” he says. But while some people under this umbrella will be stridently opposed to vaccines for various reasons, not all of them will be. Some may be unsure or ambivalent. Some might have specific fears, perhaps about side effects or even about needle injections.

Vaccine hesitancy is shared by “a very heterogeneous group,” says Kantor. That group includes “everyone from those who have a little bit of wariness … and want a little bit more information … to those who are strongly opposed and feel that it is their mission in life to spread the gospel regarding the risks of vaccination.”

To begin understanding where individuals sit on this spectrum and why, Kantor and his colleagues scoured published research on vaccine hesitancy. They sent surveys to 50 people, asking them detailed questions about their feelings on vaccines. The researchers were looking for themes: Which issues kept cropping up?

They found that prominent concerns about vaccines tend to fall into three categories: beliefs, pain, and deliberation. Beliefs might be along the lines of “It is unhealthy for children to be vaccinated as much as they are today.” Concerns around pain center more on the immediate consequences of the vaccination, such as fears about the injection. And deliberation refers to the need some people feel to “do their own research.”

Kantor and his colleagues used their findings to develop a 13-question survey, which they trialed in 500 people from the UK and 500 more from the US. They found that responses to the questionnaire could predict whether someone had been vaccinated against covid-19.

Theirs is not the first vaccine hesitancy scale out there—similar questionnaires have been developed by others, often focusing on parents’ feelings about their children’s vaccinations. But Kantor says this is the first to incorporate the theme of deliberation—a concept that seems to have become more popular during the early days of covid-19 vaccination rollouts.

Nicole Vike at the University of Cincinnati and her colleagues are taking a different approach. They say research has suggested that how people feel about risks and rewards seems to influence whether they get vaccinated (although not necessarily in a simple or direct manner).

Vike’s team surveyed over 4,000 people to better understand this link, asking them information about themselves and how they felt about a series of pictures of sports, nature scenes, cute and aggressive animals, and so on. Using machine learning, they built a model that could predict, from these results, whether a person would be likely to get vaccinated against covid-19.

This survey could be easily distributed to thousands of people and is subtle enough that people taking it might not realize it is gathering information about their vaccine choices, Vike and her colleagues wrote in a paper describing their research. And the information collected could help public health centers understand where there is demand for vaccines, and conversely, where outbreaks of vaccine-preventable diseases might be more likely.

Models like these could be helpful in combating vaccine hesitancy, says Ashlesha Kaushik, vice president of the Iowa Chapter of the American Academy of Pediatrics. The information could enable health agencies to deliver tailored information and support to specific communities that share similar concerns, she says.

Kantor, who is a practicing physician, hopes his questionnaire could offer doctors and other health professionals insight into their patients’ concerns and suggest ways to address them. It isn’t always practical for doctors to sit down with their patients for lengthy, in-depth discussions about the merits and shortfalls of vaccines. But if a patient can spend a few minutes filling out a questionnaire before the appointment, the doctor will have a starting point for steering a respectful and fruitful conversation about the subject.

When it comes to vaccine hesitancy, we need all the insight we can get. Vaccines prevent millions of deaths every year. One and half million children under the age of five die every year from vaccine-preventable diseases, according to the children’s charity UNICEF. In 2019, the World Health Organization included “vaccine hesitancy” on its list of 10 threats to global health.

When vaccination rates drop, we start to see outbreaks of the diseases the vaccines protect against. We’ve seen this a lot recently with measles, which is incredibly infectious. Sixteen measles outbreaks were reported in the US in 2024.

Globally, over 22 million children missed their first dose of the measles vaccine in 2023, and measles cases rose by 20%. Over 107,000 people around the world died from measles that year, according to the US Centers for Disease Control and Prevention. Most of them were children.

Vaccine hesitancy is dangerous. “It’s really creating a threatening environment for these vaccine-preventable diseases to make a comeback,” says Kaushik. 

Kantor agrees: “Anything we can do to help mitigate that, I think, is great.”


Now read the rest of The Checkup

Read more from MIT Technology Review‘s archive

In 2021, my former colleague Tanya Basu wrote a guide to having discussions about vaccines with people who are hesitant. Kindness and nonjudgmentalism will get you far, she wrote.

In December 2020, as covid-19 ran rampant around the world, doctors took to social media platforms like TikTok to allay fears around the vaccine. Sharing their personal experiences was important—but not without risk, A.W. Ohlheiser reported at the time.

Robert F. Kennedy Jr. is currently in the spotlight for his views on vaccines. But he has also spread harmful misinformation about HIV and AIDS, as Anna Merlan reported.

mRNA vaccines have played a vital role in the covid-19 pandemic, and in 2023, the researchers who pioneered the science behind them were awarded a Nobel Prize. Here’s what’s next for mRNA vaccines.

Vaccines are estimated to have averted 154 million deaths in the last 50 years. That number includes 146 million children under the age of five. That’s partly why childhood vaccines are a public health success story.

From around the web

As Robert F. Kennedy Jr.’s Senate hearing continued this week, so did the revelations of his misguided beliefs about health and vaccines. Kennedy, who has called himself “an expert on vaccines,” said in 2021 that “we should not be giving Black people the same vaccine schedule that’s given to whites, because their immune system is better than ours”—a claim that is not supported by evidence. (The Washington Post)

And in past email exchanges with his niece, a primary-care physician at NYC Health + Hospitals in New York City, RFK Jr. made repeated false claims about covid-19 vaccinations and questioned the value of annual flu vaccinations. (STAT)

Towana Looney, who became the third person to receive a gene-edited pig kidney in December, is still healthy and full of energy two months later. The milestone makes Looney the longest-living recipient of a pig organ transplant. “I’m superwoman,” she told the Associated Press. (AP)

The Trump administration’s attempt to freeze trillions of dollars in federal grants, loans, and other financial assistance programs was chaotic. Even a pause in funding for global health programs can be considered a destruction, writes Atul Gawande. (The New Yorker)

How ultraprocessed is the food in your diet? This chart can help rank food items—but won’t tell you all you need to know about how healthy they are. (Scientific American)

Mice with two dads have been created using CRISPR

Mice with two fathers have been born—and have survived to adulthood—following a complex set of experiments by a team in China. 

Zhi-Kun Li at the Chinese Academy of Sciences in Beijing and his colleagues used CRISPR to create the mice, using a novel approach to target genes that normally need to be inherited from both male and female parents. They hope to use the same approach to create primates with two dads. 

Humans are off limits for now, but the work does help us better understand a strange biological phenomenon known as imprinting, which causes certain genes to be expressed differently depending on which parent they came from. For these genes, animals inherit part of a “dose” from each parent, and the two must work in harmony to create a healthy embryo. Without both doses, gene expression can go awry, and the resulting embryos can end up with abnormalities.

This is what researchers have found in previous attempts to create mice with two dads. In the 1980s, scientists in the UK tried injecting the DNA-containing nucleus of a sperm cell into a fertilized egg cell. The resulting embryos had DNA from two males (as well as a small amount of DNA from a female, in the cytoplasm of the egg).

But when these embryos were transferred to the uteruses of surrogate mouse mothers, none of them resulted in a healthy birth, seemingly because imprinted genes from both paternal and maternal genomes are needed for development. 

Li and his colleagues took a different approach. The team used gene editing to knock out imprinted genes altogether.

Around 200 of a mouse’s genes are imprinted, but Li’s team focused on 20 that are known to be important for the development of the embryo.

In an attempt to create healthy mice with DNA from two male “dads,” the team undertook a complicated set of experiments. To start, the team cultured cells with sperm DNA to collect stem cells in the lab. Then they used CRISPR to disrupt the 20 imprinted genes they were targeting.

These gene-edited cells were then injected, along with other sperm cells, into egg cells that had had their own nuclei removed. The result was embryonic cells with DNA from two male mice. These cells were then injected into a type of “embryo shell” used in research, which provides the cells required to make a placenta. The resulting embryos were transferred to the uteruses of female mice.

It worked—to some degree. Some of the embryos developed into live pups, and they even survived to adulthood. The findings were published in the journal Cell Stem Cell.

“It’s exciting,” says Kotaro Sasaki, a developmental biologist at the University of Pennsylvania, who was not involved in the work. Not only have Li and his team been able to avoid a set of imprinting defects, but their approach is the second way scientists have found to create mice using DNA from two males.

The finding builds on research by Katsuhiko Hayashi, now at Osaka University in Japan, and his colleagues. A couple of years ago, that team presented evidence that they had found a way to take cells from the tails of adult male mice and turn them into immature egg cells. These could be fertilized with sperm to create bi-paternal embryos. The mice born from those embryos can reach adulthood and have their own offspring, Hayashi has said.

Li’s team’s more complicated approach was less successful. Only a small fraction of the mice survived, for a start. The team transferred 164 gene-edited embryos, but only seven live pups were born. And those that were born weren’t entirely normal, either. They grew to be bigger than untreated mice, and their organs appeared enlarged. They didn’t live as long as normal mice, and they were infertile.

It would be unethical to do such risky research with human cells and embryos. “Editing 20 imprinted genes in humans would not be acceptable, and producing individuals who could not be healthy or viable is simply not an option,” says Li.

“There are numerous issues,” says Sasaki. For a start, a lot of the technical lab procedures the team used have not been established for human cells. But even if we had those, this approach would be dangerous—knocking out human genes could have untold health consequences. 

“There’s lots and lots of hurdles,” he says. “Human applications [are] still quite far.”

Despite that, the work might shed a little more light on the mysterious phenomenon of imprinting. Previous research has shown that mice with two moms appear smaller, and live longer than expected, while the current study shows that mice with two dads are overgrown and die more quickly. Perhaps paternal imprinted genes support growth and maternal ones limit it, and animals need both to reach a healthy size, says Sasaki.

The US withdrawal from the WHO will hurt us all

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.

On January 20, his first day in office, US president Donald Trump signed an executive order to withdraw the US from the World Health Organization. “Ooh, that’s a big one,” he said as he was handed the document.

The US is the biggest donor to the WHO, and the loss of this income is likely to have a significant impact on the organization, which develops international health guidelines, investigates disease outbreaks, and acts as an information-sharing hub for member states.

But the US will also lose out. “It’s a very tragic and sad event that could only hurt the United States in the long run,” says William Moss, an epidemiologist at Johns Hopkins Bloomberg School of Public Health in Baltimore.

Trump appears to take issue with the amount the US donates to the WHO. He points out that it makes a much bigger contribution than China, a country with a population four times that of the US. “It seems a little unfair to me,” he said as he prepared to sign the executive order.

It is true that the US is far and away the biggest financial supporter of the WHO. The US contributed $1.28 billion over the two-year period covering 2022 and 2023. By comparison, the second-largest donor, Germany, contributed $856 million in the same period. The US currently contributes 14.5% of the WHO’s total budget.

But it’s not as though the WHO sends a billion-dollar bill to the US. All member states are required to pay membership dues, which are calculated as a percentage of a country’s gross domestic product. For the US, this figure comes to $130 million. China pays $87.6 million. But the vast majority of the US’s contributions to the WHO are made on a voluntary basis—in recent years, the donations have been part of multibillion-dollar spending on global health by the US government. (Separately, the Bill and Melinda Gates Foundation contributed $830 million over 2022 and 2023.)

There’s a possibility that other member nations will increase their donations to help cover the shortfall left by the US’s withdrawal. But it is not clear who will step up—or what implications it will have to change the structure of donations.

Martin McKee, a professor of European public health at the London School of Hygiene and Tropical Medicine, thinks it is unlikely that European members will increase their contributions by much. China, India, Brazil, South Africa, and the Gulf states, on the other hand, may be more likely to pay more. But again, it isn’t clear how this will pan out, or whether any of these countries will expect greater influence over global health policy decisions as a result of increasing their donations.

WHO funds are spent on a range of global health projects—programs to eradicate polio, rapidly respond to health emergencies, improve access to vaccines and medicines, develop pandemic prevention strategies, and more. The loss of US funding is likely to have a significant impact on at least some of these programs.

“Diseases don’t stick to national boundaries, hence this decision is not only concerning for the US, but in fact for every country in the world,” says Pauline Scheelbeek at the London School of Hygiene and Tropical Medicine.“With the US no longer reporting to the WHO nor funding part of this process, the evidence on which public health interventions and solutions should be based is incomplete.”

“It’s going to hurt global health,” adds Moss. “It’s going to come back to bite us.”

There’s more on how the withdrawal could affect health programs, vaccine coverage, and pandemic preparedness in this week’s coverage.


Now read the rest of The Checkup

Read more from MIT Technology Review‘s archive

This isn’t the first time Donald Trump has signaled his desire for the US to leave the WHO. He proposed a withdrawal during his last term, in 2020. While the WHO is not perfect, it needs more power and funding, not less, Charles Kenny, director of technology and development at the Center for Global Development, argued at the time.

The move drew condemnation from those working in public health then, too. The editor in chief of the medical journal The Lancet called it “a crime against humanity,” as Charlotte Jee reported.

In 1974, the WHO launched an ambitious program to get lifesaving vaccines to all children around the world. Fifty years on, vaccines are thought to have averted 154 million deaths—including 146 million in children under the age of five. 

The WHO has also seen huge success in its efforts to eradicate polio. Today, wild forms of the virus have been eradicated in all but two countries. But vaccine-derived forms of the virus can still crop up around the world.

At the end of a round of discussions in September among WHO member states working on a pandemic agreement, director-general Tedros Adhanom Ghebreyesus remarked, “The next pandemic will not wait for us, whether from a flu virus like H5N1, another coronavirus, or another family of viruses we don’t yet know about.” The H5N1 virus has been circulating on US dairy farms for months now, and the US is preparing for potential human outbreaks.

From around the web

People with cancer paid $45,000 for an experimental blood-filtering treatment, delivered at a clinic in Antigua, after being misled about its effectiveness. Six of them have died since their treatments. (The New York Times)

The Trump administration has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites, and social media posts. (The Washington Post)

A new “virtual retina,” modeled on human retinas, has been developed to study the impact of retinal implants. The three-dimensional model simulates over 10,000 neurons. (Brain Stimulation)

Trump has signed an executive order stating that “it is the policy of the United States to recognize two sexes, male and female.” The document “defies decades of research into how human bodies grow and develop,” STAT reports, and represents “a dramatic failure to understand biology,” according to a neuroscientist who studies the development of sex. (STAT)

Attention, summer holiday planners: Biting sandflies in the Mediterranean region are transmitting Toscana virus at an increasing rate. The virus is a major cause of central nervous system disorders in the region. Italy saw a 2.6-fold increase in the number of reported infections between the 2016–21 period and 2022–23. (Eurosurveillance)

This is what might happen if the US withdraws from the WHO

On January 20, his first day in office, US president Donald Trump signed an executive order to withdraw the US from the World Health Organization. “Ooh, that’s a big one,” he said as he was handed the document.

The US is the biggest donor to the WHO, and the loss of this income is likely to have a significant impact on the organization, which develops international health guidelines, investigates disease outbreaks, and acts as an information-sharing hub for member states.

But the US will also lose out. “It’s a very tragic and sad event that could only hurt the United States in the long run,” says William Moss, an epidemiologist at Johns Hopkins Bloomberg School of Public Health in Baltimore.

A little unfair?

Trump appears to take issue with the amount the US donates to the WHO. He points out that it makes a much bigger contribution than China, a country with a population four times that of the US. “It seems a little unfair to me,” he said as he prepared to sign the executive order.

It is true that the US is far and away the biggest financial supporter of the WHO. The US contributed $1.28 billion over the two-year period covering 2022 and 2023. By comparison, the second-largest donor, Germany, contributed $856 million in the same period. The US currently contributes 14.5% of the WHO’s total budget.

But it’s not as though the WHO sends a billion-dollar bill to the US. All member states are required to pay membership dues, which are calculated as a percentage of a country’s gross domestic product. For the US, this figure comes to $130 million. China pays $87.6 million. But the vast majority of the US’s contributions to the WHO are made on a voluntary basis—in recent years, the donations have been part of multibillion-dollar spending on global health by the US government. (Separately, the Bill and Melinda Gates Foundation contributed $830 million over 2022 and 2023.)

There’s a possibility that other member nations will increase their donations to help cover the shortfall left by the US’s withdrawal. But it is not clear who will step up—or what implications changing the structure of donations will have.

Martin McKee, a professor of European public health at the London School of Hygiene and Tropical Medicine, thinks it is unlikely that European members will increase their contributions by much. The Gulf states, China, India, Brazil, and South Africa, on the other hand, may be more likely to pay more. But again, it isn’t clear how this will pan out, or whether any of these countries will expect greater influence over global health policy decisions as a result of increasing their donations.

Deep impacts

WHO funds are spent on a range of global health projects—programs to eradicate polio, rapidly respond to health emergencies, improve access to vaccines and medicines, develop pandemic prevention strategies, and more. The loss of US funding is likely to have a significant impact on at least some of these programs.

It is not clear which programs will lose funding, or when they will be affected. The US is required to give 12 months’ notice to withdraw its membership, but voluntary contributions might stop before that time is up. 

For the last few years, WHO member states have been negotiating a pandemic agreement designed to improve collaboration on preparing for future pandemics. The agreement is set to be finalized in 2025. But these discussions will be disrupted by the US withdrawal, says McKee. It will “create confusion about how effective any agreement will be and what it will look like,” he says.

The agreement itself won’t make as big an impact without the US as a signatory, either, says Moss, who is also a member of a WHO vaccine advisory committee. The US would not be held to information-sharing standards that other countries could benefit from, and it might not be privy to important health information from other member nations. The global community might also lose out on the US’s resources and expertise. “Having a major country like the United States not be a part of that really undermines the value of any pandemic agreement,” he says.

McKee thinks that the loss of funding will also affect efforts to eradicate polio, and to control outbreaks of mpox in the Democratic Republic of Congo, Uganda, and Burundi, which continue to report hundreds of cases per week. The virus “has the potential to spread, including to the US,” he points out.

“Diseases don’t stick to national boundaries, hence this decision is not only concerning for the US, but in fact for every country in the world,” says Pauline Scheelbeek at the London School of Hygiene and Tropical Medicine. “With the US no longer reporting to the WHO nor funding part of this process, the evidence on which public health interventions and solutions should be based is incomplete.”

Moss is concerned about the potential for outbreaks of vaccine-preventable diseases. Robert F. Kennedy Jr., Trump’s pick to lead the Department of Health and Human Services, is a prominent antivaccine advocate, and Moss worries about potential changes to vaccination-based health policies in the US. That, combined with a weakening of the WHO’s ability to control outbreaks, could be a “double whammy,” he says: “We’re setting ourselves up for large measles disease outbreaks in the United States.”

At the same time, the US is up against another growing threat to public health: the circulation of bird flu on poultry and dairy farms. The US has seen outbreaks of the H5N1 virus on poultry farms in all states, and the virus has been detected in 928 dairy herds across 16 states, according to the US Centers for Disease Control and Prevention. There have been 67 reported human cases in the US, and one person has died. While we don’t yet have evidence that the virus can spread between people, the US and other countries are already preparing for potential outbreaks.

But this preparation relies on a thorough and clear understanding of what is happening on the ground. The WHO provides an important role in information sharing—countries report early signs of outbreaks to the agency, which then shares the information with its members. This kind of information not only allows countries to develop strategies to limit the spread of disease but can also allow them to share genetic sequences of viruses and develop vaccines. Member nations need to know what’s happening in the US, and the US needs to know what’s happening globally. “Both of those channels of communication would be hindered by this,” says Moss.

As if all of that weren’t enough, the US also stands to suffer in terms of its reputation as a leader in global public health. “By saying to the world ‘We don’t care about your health,’ it sends a message that is likely to reflect badly on it,” says McKee. “It’s a classic lose-lose situation.”

“It’s going to hurt global health,” says Moss. “It’s going to come back to bite us.”

Update: this article was amended to include commentary from Pauline Scheelbeek.

What to expect from Neuralink in 2025

MIT Technology Review’s What’s Next series looks across industries, trends, and technologies to give you a first look at the future. You can read the rest of them here.

In November, a young man named Noland Arbaugh announced he’d be livestreaming from his home for three days straight. His broadcast was in some ways typical fare: a backyard tour, video games, meet mom.

The difference is that Arbaugh, who is paralyzed, has thin electrode-studded wires installed in his brain, which he used to move a computer mouse on a screen, click menus, and play chess. The implant, called N1, was installed last year by neurosurgeons working with Neuralink, Elon Musk’s brain-interface company.

The possibility of listening to neurons and using their signals to move a computer cursor was first demonstrated more than 20 years ago in a lab setting. Now, Arbaugh’s livestream is an indicator that Neuralink is a whole lot closer to creating a plug-and-play experience that can restore people’s daily ability to roam the web and play games, giving them what the company has called “digital freedom.”

But this is not yet a commercial product. The current studies are small-scale—they are true experiments, explorations of how the device works and how it can be improved. For instance, at some point last year, more than half the electrode-studded “threads” inserted into Aurbaugh’s brain retracted, and his control over the device worsened; Neuralink rushed to implement fixes so he could use his remaining electrodes to move the mouse.

Neuralink did not reply to emails seeking comment, but here is what our analysis of its public statements leads us to expect from the company in 2025.

More patients

How many people will get these implants? Elon Musk keeps predicting huge numbers. In August, he posted on X: “If all goes well, there will be hundreds of people with Neuralinks within a few years, maybe tens of thousands within five years, millions within 10 years.”

In reality, the actual pace is slower—a lot slower. That’s because in a study of a novel device, it’s typical for the first patients to be staged months apart, to allow time to monitor for problems. 

Neuralink has publicly announced that two people have received an implant: Arbaugh and a man referred to only as “Alex,” who received his in July or August. 

Then, on January 8, Musk disclosed during an online interview that there was now a third person with an implant. “We’ve got now three patients, three humans with Neuralinks implanted, and they are all working …well,” Musk said. During 2025, he added, “we expect to hopefully do, I don’t know, 20 or 30 patients.”  

Barring major setbacks, expect the pace of implants to increase—although perhaps not as fast as Musk says. In November, Neuralink updated its US trial listing to include space for five volunteers (up from three), and it also opened a trial in Canada with room for six. Considering these two studies only, Neuralink would carry out at least two more implants by the end of 2025 and eight by the end of 2026.

However, by opening further international studies, Neuralink could increase the pace of the experiments.

Better control

So how good is Arbaugh’s control over the mouse? You can get an idea by trying a game called Webgrid, where you try to click quickly on a moving target. The program translates your speed into a measure of information transfer: bits per second. 

Neuralink claims Arbaugh reached a rate of over nine bits per second, doubling the old brain-interface record. The median able-bodied user scores around 10 bits per second, according to Neuralink.

And yet during his livestream, Arbaugh complained that his mouse control wasn’t very good because his “model” was out of date. It was a reference to how his imagined physical movements get mapped to mouse movements. That mapping degrades over hours and days, and to recalibrate it, he has said, he spends as long as 45 minutes doing a set of retraining tasks on his monitor, such as imagining moving a dot from a center point to the edge of a circle.

Noland Arbaugh stops to calibrate during a livestream on X
@MODDEDQUAD VIA X

Improving the software that sits between Arbaugh’s brain and the mouse is a big area of focus for Neuralink—one where the company is still experimenting and making significant changes. Among the goals: cutting the recalibration time to a few minutes. “We want them to feel like they are in the F1 [Formula One] car, not the minivan,” Bliss Chapman, who leads the BCI software team, told the podcaster Lex Fridman last year.

Device changes

Before Neuralink ever seeks approval to sell its brain interface, it will have to lock in a final device design that can be tested in a “pivotal trial” involving perhaps 20 to 40 patients, to show it really works as intended. That type of study could itself take a year or two to carry out and hasn’t yet been announced.

In fact, Neuralink is still tweaking its implant in significant ways—for instance, by trying to increase the number of electrodes or extend the battery life. This month, Musk said the next human tests would be using an “upgraded Neuralink device.”

The company is also still developing the surgical robot, called R1, that’s used to implant the device. It functions like a sewing machine: A surgeon uses R1 to thread the electrode wires into people’s brains. According to Neuralink’s job listings, improving the R1 robot and making the implant process entirely automatic is a major goal of the company. That’s partly to meet Musk’s predictions of a future where millions of people have an implant, since there wouldn’t be enough neurosurgeons in the world to put them all in manually. 

“We want to get to the point where it’s one click,” Neuralink president Dongjin Seo told Fridman last year.

Robot arm

Late last year, Neuralink opened a companion study through which it says some of its existing implant volunteers will get to try using their brain activity to control not only a computer mouse but other types of external devices, including an “assistive robotic arm.”

We haven’t yet seen what Neuralink’s robotic arm looks like—whether it’s a tabletop research device or something that could be attached to a wheelchair and used at home to complete daily tasks.

But it’s clear such a device could be helpful. During Aurbaugh’s livestream he frequently asked other people to do simple things for him, like brush his hair or put on his hat.

Arbaugh demonstrates the use of Imagined Movement Control.
@MODDEDQUAD VIA X

And using brains to control robots is definitely possible—although so far only in a controlled research setting. In tests using a different brain implant, carried out at the University of Pittsburgh in 2012, a paralyzed woman named Jan Scheuermann was able to use a robot arm to stack blocks and plastic cups about as well as a person who’d had a severe stroke—impressive, since she couldn’t actually move her own limbs.

There are several practical obstacles to using a robot arm at home. One is developing a robot that’s safe and useful. Another, as noted by Wired, is that the calibration steps to maintain control over an arm that can make 3D movements and grasp objects could be onerous and time consuming.

Vision implant

In September, Neuralink said it had received “breakthrough device designation” from the FDA for a version of its implant that could be used to restore limited vision to blind people. The system, which it calls Blindsight, would work by sending electrical impulses directly into a volunteer’s visual cortex, producing spots of light called phosphenes. If there are enough spots, they can be organized into a simple, pixelated form of vision, as previously demonstrated by academic researchers.

The FDA designation is not the same as permission to start the vision study. Instead, it’s a promise by the agency to speed up review steps, including agreements around what a trial should look like. Right now, it’s impossible to guess when a Neuralink vision trial could start, but it won’t necessarily be this year. 

More money

Neuralink last raised money in 2023, collecting around $325 million from investors in a funding round that valued the company at over $3 billion, according to Pitchbook. Ryan Tanaka, who publishes a podcast about the company, Neura Pod, says he thinks Neuralink will raise more money this year and that the valuation of the private company could double.

Fighting regulators

Neuralink has attracted plenty of scrutiny from news reporters, animal-rights campaigners, and even fraud investigators at the Securities and Exchange Commission. Many of the questions surround its treatment of test animals and whether it rushed to try the implant in people.

More recently, Musk has started using his X platform to badger and bully heads of state and was named by Donald Trump to co-lead a so-called Department of Government Efficiency, which Musk says will “get rid of nonsensical regulations” and potentially gut some DC agencies. 

During 2025, watch for whether Musk uses his digital bullhorn to give health regulators pointed feedback on how they’re handling Neuralink.

Other efforts

Don’t forget that Neuralink isn’t the only company working on brain implants. A company called Synchron has one that’s inserted into the brain through a blood vessel, which it’s also testing in human trials of brain control over computers. Other companies, including Paradromics, Precision Neuroscience, and BlackRock Neurotech, are also developing advanced brain-computer interfaces.

Special thanks to Ryan Tanaka of Neura Pod for pointing us to Neuralink’s public announcements and projections.

Deciding the fate of “leftover” embryos

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.

Over the past few months, I’ve been working on a piece about IVF embryos. The goal of in vitro fertilization is to create babies via a bit of lab work: Trigger the release of lots of eggs, introduce them to sperm in a lab, transfer one of the resulting embryos into a person’s uterus, and cross your fingers for a healthy pregnancy. Sometimes it doesn’t work. But often it does. For the article, I explored what happens to the healthy embryos that are left over.

I spoke to Lisa Holligan, who had IVF in the UK around five years ago. Holligan donated her “genetically abnormal” embryos for scientific research. But she still has one healthy embryo frozen in storage. And she doesn’t know what to do with it.

She’s not the only one struggling with the decision. “Leftover” embryos are kept frozen in storage tanks, where they sit in little straws, invisible to the naked eye, their growth paused in a state of suspended animation. What happens next is down to personal choice—but that choice can be limited by a complex web of laws and ethical and social factors.

These days, responsible IVF clinics will always talk to people about the possibility of having leftover embryos before they begin treatment. Intended parents will sign a form indicating what they would like to happen to those embryos. Typically, that means deciding early on whether they might like any embryos they don’t end up using to be destroyed or donated, either to someone else trying to conceive or for research.

But it can be really difficult to make these decisions before you’ve even started treatment. People seeking fertility treatment will usually have spent a long time trying to get pregnant. They are hoping for healthy embryos, and some can’t imagine having any left over—or how they might feel about them.

For a lot of people, embryos are not just balls of cells. They hold the potential for life, after all. Some people see them as children, waiting to be born. Some even name their embryos, or call them their “freezer babies.” Others see them as the product of a long, exhausting, and expensive IVF journey.

Holligan says that she initially considered donating her embryo to another person, but her husband disagreed. He saw the embryo as their child and said he wouldn’t feel comfortable with giving it up to another family. “I started having these thoughts about a child coming to me when they’re older, saying they’ve had a terrible life, and [asking] ‘Why didn’t you have me?’” she told me.

Holligan lives in the UK, where you can store your embryos for up to 55 years. Destroying or donating them are also options. That’s not the case in other countries. In Italy, for example, embryos cannot be destroyed or donated. Any that are frozen will remain that way forever, unless the law changes at some point.

In the US, regulations vary by state. The patchwork of laws means that one state can bestow a legal status on embryos, giving them the same rights as children, while another might have no legislation in place at all.

No one knows for sure how many embryos are frozen in storage tanks, but the figure is thought to be somewhere between 1 million and 10 million in the US alone. Some of these embryos have been in storage for years or decades. In some cases, the intended parents have deliberately chosen this, opting to pay hundreds of dollars per year in fees.

But in other cases, clinics have lost touch with their clients. Many of these former clients have stopped paying for the storage of their embryos, but without up-to-date consent forms, clinics can be reluctant to destroy them. What if the person comes back and wants to use those embryos after all?

“Most clinics, if they have any hesitation or doubt or question, will err on the side of holding on to those embryos and not discarding them,” says Sigal Klipstein, a reproductive endocrinologist at InVia Fertility Center in Chicago, who also chairs the ethics committee of the American Society for Reproductive Medicine. “Because it’s kind of like a one-way ticket.”

Klipstein thinks one of the reasons why some embryos end up “abandoned” in storage is that the people who created them can’t bring themselves to destroy them. “It’s just very emotionally difficult for someone who has wanted so much to have a family,” she tells me.

Klipstein says she regularly talks to her patients about what to do with leftover embryos. Even people who make the decision with confidence can change their minds, she says. “We’ve all had those patients who have discarded embryos and then come back six months or a year later and said: ‘Oh, I wish I had those embryos,’” she tells me. “Those [embryos may have been] their best chance of pregnancy.”

Those who do want to discard their embryos have options. Often, the embryos will simply be exposed to air and then disposed of. But some clinics will also offer to transfer them at a time or place where a pregnancy is extremely unlikely to result. This “compassionate transfer,” as it is known, might be viewed as a more “natural” way to dispose of the embryo.

But it’s not for everyone. Holligan has experienced multiple miscarriages and wonders if a compassionate transfer might feel similar. She wonders if it might just end up “putting [her] body and mind through unnecessary stress.”

Ultimately, for Holligan and many others in a similar position, the choice remains a difficult one. “These are … very desired embryos,” says Klipstein. “The purpose of going through IVF was to create embryos to make babies. And [when people] have these embryos, and they’ve completed their family plan, they’re in a place they couldn’t have imagined.”


Now read the rest of The Checkup

Read more from MIT Technology Review‘s archive

Our relationship with embryos is unique, and a bit all over the place. That’s partly because we can’t agree on their moral status. Are they more akin to people or property, or something in between? Who should get to decide their fate? While we get to the bottom of these sticky questions, millions of embryos are stuck in suspended animation—some of them indefinitely.

It is estimated that over 12 million babies have been born through IVF. The development of the Nobel Prize–winning technology behind the procedure relied on embryo research. Some worry that donating embryos for research can be onerous—and that valuable embryos are being wasted as a result.

Fertility rates around the world are dropping below the levels needed to maintain stable populations. But IVF can’t save us from a looming fertility crisis. Gender equality and family-friendly policies are much more likely to prove helpful

Two years ago, the US Supreme Court overturned Roe v. Wade, a legal decision that protected the right to abortion. Since then, abortion bans have been enacted in multiple states. But in November of last year, some states voted to extend and protect access to abortion, and voters in Missouri supported overturning the state’s ban.

Last year, a ruling by the Alabama Supreme Court that embryos count as children ignited fears over access to fertility treatments in a state that had already banned abortion. The move could also have implications for the development of technologies like artificial uteruses and synthetic embryos, my colleague Antonio Regalado wrote at the time.

From around the web

It’s not just embryos that are frozen as part of fertility treatments. Eggs, sperm, and even ovarian and testicular tissue can be stored too. A man who had immature testicular tissue removed and frozen before undergoing chemotherapy as a child 16 years ago had the tissue reimplanted in a world first, according to the team at University Hospital Brussels that performed the procedure around a month ago. The tissue was placed into the man’s testicle and scrotum, and scientists will wait a year before testing to see if he is successfully producing sperm. (UZ Brussel)

The Danish pharmaceutical company Novo Nordisk makes half the world’s insulin. Now it is better known as the manufacturer of the semaglutide drug Ozempic. How will the sudden shift affect the production and distribution of these medicines around the world? (Wired)

The US has not done enough to prevent the spread of the H5N1 virus in dairy cattle. The response to bird flu is a national embarrassment, argues Katherine J. Wu. (The Atlantic)

Elon Musk has said that if all goes well, millions of people will have brain-computer devices created by his company Neuralink implanted within 10 years. In reality, progress is slower—so far, Musk has said that three people have received the devices. My colleague Antonio Regalado predicts what we can expect from Neuralink in 2025. (MIT Technology Review)